Chinese Inv
vestors Lookiing for Future Unicorns- sstartup competition in life science
Cambridgge, MA (Jan.. 28th, 2016) Nanjing Bio
oSciKin Co., Ltd (“BioSciKKin” or “BSK
K” or the “Compan
ny”), an open investmen
nt and incubaation platforrm in China for life scien
nce innovatio
on, announced today thaat the Comp
pany is sponssoring an intternational sstartup contest in life science, e
especially in
n precision m
medicine and
d e‐health. TThe co‐sponssors include influential Chinese iindustrial invvestors, phaarmaceuticall companies and Chinesee media with
h the support of a powerful alliance of strategic investors. The event r uns from Jan
nuary to Maay 2016. It w
will take placce in 8 cities in both Chin
na and the U
US, with the US preliminaaries held in
n San Francissco and Boston. Sponsors are:
a
● Simcere Pharmaceutical Group
p ● BioSciK
Kin
● Simceree State Key Laaboratory of Translational Medicine
M
and IInnovative Druug R&D
● HEALTH
HCARE EXEC
CUTIVE Magaazine
● Fireston
ne Investing
uld apply?
Who shou
The event welcomes botth companies and entrepren
neurial teams iin Life sciencee, especially inn precision
o e-health rellated areas, inccluding but no
ot limited to: ccompanion diaagnostic couplled medicine, Gene
medicine or
Therapy, Cell
C Therapy, Stem Cell, Biio-bank, Biom
marker discoveery, NGS, Mollecular Diagnoostics, POCT, eHealth, 3D
D Printing, Big
g Data, etc.
Rewards for winners:




For each
e
preliminaary in the US: $30,000 for fiirst prize (1 wiinner), and thee prize moneyy is non-dilutivve.
Trip to
t Shanghai to
o attend final competition
c
in
n May 2016 foor the top two finalists from
m each preliminnary
For final
fi contestan
nts: potential sttrategic investtments from atttending invesstors
Optio
on to leveragee support from
m Simcere & BioSciKin:
B
Coollaboration oopportunities iin R&D, markketing,
distriibution etc.
W
When & Where:
East Coasst Preliminary
Date: Apriil 05, 2016
Time: 4:00
0 – 8:00 p.m. Eastern Time
Location: MassBio, 300
0 Technology Square, 8th Flloor, MassBioo Collaborationn Room, Cam
mbridge, MA 002139
Co-organiized by:
Harvard Medical
M
Schoo
ol Chinese Sch
holars and Sciientists Associiation (HMS-C
CSSA), SAPA
A-NE, MIT-CH
HIEF,
NECINA，
，CABA , 128
8 CUTE, ACM
MA
Supporting organization： MassBio
Publicity partner: Massachusetts Life Sciences Center
West Coast Preliminary
Date: April 07, 2016
Time: 6:30-10:30 p.m. Western Time
Location: Room130, Li Ka Shing Learning and Knowledge Center, 291 Campus Drive, Stanford, CA 94305
Co-organized by:
Chinese American Biopharmaceutical Society (CABS)
Association of Chinese Students and Scholars at Stanford (ACSSS)
Supporting organization: California Life Sciences Association (CLSA)
How to participate
1. Application Deadline is March 15, 2016: please send an executive summary or no more than 10 slides in
either PowerPoint or as a PDF along with your contact information to pitching@bioscikin.com (Boston) or
http://www.cabsweb.org/cabs-business-plan-contest/ (SFO).
2. About 10 startups will be selected to showcase their projects at preliminaries. You will receive a formal
invitation to the preliminaries. Two teams with the highest ratings from the judging panel will advance to
the final.
For more information, please email BSK’s US contacts and ask for a full description of this event.
East Coast: liqiangtou@gmail.com or call 617-319-8265 or West Coast: cabs_icc@cabs.org or call 626-2726619.
About Simcere
Simcere is an emerging leader in developing, manufacturing and marketing of innovative medicines and
branded generics in China. Simcere was the first Chinese chemical and biological drug company to list on the
NYSE in 2007. In 2013, the company went private for strategic considerations. In 2015, Simcere’s
translational medicine and innovative drug R&D platform was recognized as a State Key Laboratory by the
National Ministry of Science and Technology. The company has been actively pursuing cross-border
partnerships to bring global innovation to China. In Boston and New Jersey, Simcere now has two offices in
the US for accelerating international business development.
About BioSciKin
BioSciKin (BSK) is an open platform in China for life science entrepreneurs and innovators. BSK focuses on
three major healthcare areas: novel therapeutics, medical devices and mobile healthcare services, BSK is
looking for partnership from all over the world for co-development of innovative approaches in precision
medicine. In Nanjing, Shanghai and Tianjin, BSK has established 3 R&D-oriented incubation parks with
advanced R&D facilities to provide entrepreneurs with customized service and support packages. For more
information, please go to BSK’s official website: www.bioscikin.com
You can also email to Ms. Ray Zhang, Senior BD director, BioSciKin (zhangruikun@bioscikin.com )
About HEALTHCARE EXECUTIVE Magazine
HEALTHCARE EXECUTIVE is an influential magazine in the Chinese healthcare industry.
About Firestone
Firestone focuses on innovation and entrepreneurship services in the healthcare industry.
Announcement of New Office Location
Simcere is delighted to announce our recent expansion into Boston. Our new Boston-area office is located on
245 First Street, Cambridge MA 02142. This new expansion enables Simcere to provide additional functions
to all our clients, and to be a part of one of the world’s leading ecocystems for life sciences innovation in the
Greater Boston region. These additional capabilities will help Simcere in providing exceptional services to our
industry partners. Simcere worked closely with the Massachusetts Life Sciences Center and MassBio as part of
the company’s U.S. location search. For additional information, please contact Dr. Sean Cao at (617) 444 –
8778.
“The Boston/Cambridge area has evolved from a cluster of world-class research centers to the most active
global innovation hub for the biotech and pharmaceutical industries,” Dr. Cao told MassBio in an interview.
“Establishing a branch in Cambridge allows us to work very closely with up-and-coming biotechs, large
pharmas and top-notch research institutions."
“We are thrilled to welcome Simcere to the Massachusetts life sciences cluster,” said Robert K. Coughlin,
President & CEO of MassBio. “We know that they will contribute to and benefit from our community and are
pleased to see that they are already connecting with local entrepreneurs for the upcoming BioSciKin startup
competition.”
“We are excited to welcome Simcere, a leading pharmaceutical company in China, to their new office in
Cambridge,” said Travis McCready, President & CEO of the Massachusetts Life Sciences Center. “They are
joining a growing concentration of Chinese life sciences companies that are choosing Massachusetts as a great
place to locate their U.S. operations. We look forward to promoting the business plan competition that
Simcere and BioSciKin are sponsoring here, that will allow promising start-ups in Massachusetts to access
investors in China.”
Simcere’s Boston office contact information:
Phone: (617) 444 – 8778
Email: sean.cao@simcere.com
sean.cao@bioscikin.com
sean.cao@bskbio.com